3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
28
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Neoplasm Metastasis
4
Lymphoma
4
Leukemia, Myeloid, Acute
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Biliary Tract Neoplasms
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Glioma
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Adenocarcinoma, Follicular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Taxes
5
Paclitaxel
5
Carboplatin
4
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
temsirolimus
1
pegfilgrastim
1
nintedanib
1
ixabepilone
1
cediranib
1
brivanib
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Metformin
1
Medroxyprogesterone Acetate
1
Medroxyprogesterone
1
MK 2206
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Epothilones
1
Doxorubicin
1
Brachytherapy
1
AZD 6244
1
ALK1-Fc fusion protein, human
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Adenocarcinoma
×
trametinib
×
Clear all
No trials found.